Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

GenMark Diagnostics Schedules Second Quarter 2013 Financial Results Conference Call for August 7, 2013

Business Wire July 29, 2013

FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark

PR Newswire June 21, 2013

Five Star Equities Issues New Research Reports on CAMT, FLIR, GNMK and TDG

Accesswire June 19, 2013

GenMark Diagnostics Updates Annual Revenue Guidance

Business Wire June 17, 2013

GenMark Diagnostics to Present at the William Blair 33rd Annual Growth Stock Conference

Business Wire June 5, 2013

GenMark Diagnostics Expands Role of Jon Faiz Kayyem, Ph.D. to Serve as Head of Research and Development

Business Wire June 4, 2013

GenMark Diagnostics to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Business Wire June 3, 2013

GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference

Business Wire May 10, 2013

GenMark Diagnostics Reports First Quarter 2013 Results

Business Wire May 8, 2013

GenMark Diagnostics Schedules First Quarter 2013 Financial Results Conference Call for May 8, 2013

Business Wire April 25, 2013

GenMark Diagnostics Reports Fourth Quarter and Year End 2012 Results

Business Wire March 12, 2013

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2012 Financial Results and Conference Call for March 12, 2013

Business Wire February 28, 2013

The Real Story Behind AEGR, GNMK, ENOC and WPI

Marketwired January 14, 2013

GenMark Diagnostics to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire January 4, 2013